Product
TPC combined with Apatinib and Camrelizumab
1 clinical trial
1 indication
Indication
Nasopharyngeal CarcinomaClinical trial
Efficacy and Safety of Nab-Paclitaxel, Cisplatin, and Capecitabine Chemotherapy Combined With Apatinib and Camrelizumab vs Gemcitabine, Cisplatin Combined With Camrelizumab for Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Nasopharyngeal Carcinoma: A Prospective, Controlled, Open-Label, Multicenter Phase 3 Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-05-30